Crown vaccine: all important questions and answers
A vaccine against the coronavirus could finally contain the pandemic. All about approvals, vaccination strategies, and side effects.
- Crown vaccines make further progress, with two vaccines to be approved
- Vaccines offer hope that the pandemic will eventually be contained successfully
- We show you everything you need to know about corona vaccines
Several promising vaccines may come close to approval in the European Union. Light at the end of the frenzy – experts finally agree
which they may contain.
A return to normalcy would then be possible at least gradually. However, many questions remain unanswered: When are the first vaccines coming? Who will be vaccinated first? What about side effects? All the answers to the most important questions about the corona vaccine.
Corona vaccine research: what is the current state?
Faced with the global corona pandemic, several companies are in a hurry
developed – successfully:
Manufacturers Biontech / Pfizer, Moderna and AstraZeneca announced in November that their vaccines
- Biontech / Pfizer and Moderna rely on mRNA vaccines. Both have already applied for approval in the EU, the process is ongoing – but a specific date has yet to be set.
- AstraZeneca has not yet applied for approval of its vectored vaccine in the EU.
As soon as one of the vaccines becomes official
is that the first vaccination should come quickly: the European Commission has already done so
Secured in the millions by all three manufacturers. Contracts also exist with Curevac from Tübingen, although nothing is known about the effectiveness of the vaccine.
Crown vaccine: is there a vaccination sequence? Who will be vaccinated first?
According to estimates by the federal government, the first vaccinations could be carried out as early as late 2020 or early 2021. In their position, the German Ethics Council, the Standing Committee on Vaccination and the National Academy of Sciences Leopoldina put forward one possibility: they recommend one
people particularly exposed to occupational or health risks.
They were, among others inhabitants
Retirement homes and nursing homes
or employees in
- In addition, according to the position, priority should be given to people who work in areas important for the state and society – e.g. Police officers and rescuers, but also
Teachers and educators.
Read about it
: Vaccination strategy: who will get vaccinated against Corona first?
Vaccinations against the Crown – is there a vaccination strategy?
Yes. The federal government has three phases of a vaccination strategy:
In Phase IA (“targeted centralized vaccination”), only a small amount of vaccine is available, so vaccination has a high priority and can only be carried out for a special group of people. In doing so, the government is following in particular the recommendations of the Permanent Vaccination Committee, Leopoldina and the German Ethics Council
people at risk
- In Phase IB (“extended centralized vaccination”) the situation improved somewhat: although there are now some more vaccines, there is still priority vaccination for those at risk.
The vaccine is only in Phase II (“broad, decentralized routine vaccination”)
A large area
and available for a larger group of people.
Vaccinations should be initially in
which are rebuilt for this purpose. This measure is necessary because some vaccines must be kept in a particularly cool place.
Read about it
: What is the corona vaccination strategy in Germany?
Will there be a requirement for corona vaccination?
on several occasions he spoke out clearly against the national compulsory corona vaccination. As long as there are no official compulsory vaccinations, they cannot be dated
employees are required to undergo vaccinations – regardless of whether it is a private or public company.
Gerald Haug, president of Leopoldina, proposes wise instead of duty
to vaccinate as many people as possible.
Newly developed crown vaccine: how do mRNA vaccines work?
Vaccine skeptics stubbornly believe that mRNA vaccines are effective
can change. This is not the point. Fabrics make it possible with:
(“Messenger RNA”) to transmit information for the production of specific antigens into muscle tissue cells, the Federal Ministry of Education and Research explains on its website.
As a result, the cell begins to build proteins that are presented to the immune system in the form of antigens – an immune response is triggered. These processes do not affect the genetic material.
This is how mRNA vaccines work.
Corona – More info on this topic
Corona: What are the side effects of vaccine candidates?
after vaccinations are quite normal. They also occur after common vaccinations such as tetanus and mumps-measles-rubella.
- Swelling or slight pain at the injection site
- Headaches and body aches or a
- slight feeling of illness.
People in studies of three of the most promising candidates today, Biontech / Pfizer, Moderna and AstraZeneca, reported similar responses.
So far, nothing is known about serious side effects or long-term consequences.
Crown pandemic: what are the candidates for the vaccine?
Current hopes lie in vaccines from Mainz-based Biontech and the American company Pfizer, the American biotechnology company Moderna and the British-Swedish company AstraZeneca.
All the details for the three vaccines
: Crown vaccines: This is great hope
Crown vaccine: how good is the Biontech / Pfizer vaccine?
The vaccine of the biotechnology company Biontech from Mainz and the American group Pfizer is an mRNA vaccine with a 95 percent success rate. The protective effect should occur one week after the second injection of the substance. An application for approval for the European Union has already been submitted. The vaccine should be stored at a very low temperature.
How does the Moderna vaccine work?
The corona vaccine of the American company Moderna is also one
. It has an efficiency of 94.5 percent. Unlike the Biontech vaccine, it can also be used in cold refrigerator temperatures: mRNA-1273 can remain effective for 30 days at 2 to 8 degrees. The approval process in the European Union is ongoing.
What is known about AstraZeneca?
was together with
developed. It provides a total effectiveness of 70 percent. An application for approval for the European Union has not yet been submitted.
I was excited in September
treated with AstraZeneca after the patient developed myelitis. However, according to the expert committee, this should not be related to vaccination.
What is Curevac?
Another promising vaccine may be a candidate from Tübingen
his. However, nothing is known about the effectiveness of the vaccine. It is also an mRNA vaccine that Curevac intends to test shortly in Phase 3.
(raer / mit dpa / afp)
Corona – More on this